Breaking News, Collaborations & Alliances

Merck, Mayo Clinic Partner to Support Drug Discovery & Development with AI

Agreement combines Mayo Clinic's clinical insights, genomic data and Platform architecture with Merck's AI and ML research capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Merck and Mayo Clinic, a top-ranked hospital system, have announced a research and development agreement to apply artificial intelligence (AI), advanced analytics and multimodal clinical data to support drug discovery and development. The agreement integrates Mayo Clinic’s Platform architecture as well as clinical and genomic datasets with Merck’s ambition to harness AI-enabled virtual cell technologies to enhance disease understanding, improve target identification and drive earl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters